Atlas Trials

A Study to Evaluate SAGE-217 in Participants With Moderate to Severe Major Depressive Disorder

Clinical trial NCT03000530 · COMPLETED

Trial details

NCT number
NCT03000530
Sponsor
Biogen
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Major Depression
Start date
2016-12-07
Primary completion
2017-10-04
Enrollment
102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.